Rubric Capital Management Comments on Mereo BioPharma Updated Operating Plan

Author's Avatar
Oct 18, 2022

Rubric Capital Management LP (“Rubric”), an investment advisor whose funds and accounts collectively own approximately 14% of the outstanding equity of Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the “Company”), today issued the following statement in response to the Company’s updated operating plan: